Logotype for Avicanna Inc

Avicanna (AVCN) investor relations material

Avicanna Status Update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Avicanna Inc
Status Update summary17 Dec, 2025

Business model and strategic evolution

  • Transitioned from pharmaceutical R&D to commercializing medical cannabis products, leveraging proprietary drug delivery systems and technologies.

  • Operates four business pillars: RHO Phyto (medical products), MyMedi (medical cannabis care platform), pharmaceutical pipeline, and Aureus (API/raw materials division in Colombia).

  • Asset-light model in Canada, licensing technology to 10 licensed producers and expanding through 15 commercial channels.

  • International expansion includes exports to Europe and Australia, and collaborations in the US and South America.

  • Strategic partnerships with Fortune 100/500 and leading cannabis companies, plus ongoing M&A exploration.

Product and R&D advancements

  • Expanded commercial SKUs in Canada by 24% to 52, with increased listings and entry into new medical channels.

  • RHO Phyto portfolio includes 30 proprietary SKUs, now with minor cannabinoids, and is supported by clinical trials and real-world evidence studies.

  • Launched new patented technologies: deep tissue gel/spray, Influit (self-emulsifying system), and PwdRx (powder delivery), with promising preclinical results.

  • Aureus division now produces GACP and organic certified flower, exporting to Switzerland and targeting Europe and Australia.

  • Trunerox, a 10% CBD pharmaceutical for epilepsy, launched in Colombia, leveraging low-cost manufacturing.

Medical platform and clinical engagement

  • MyMedi platform expanded, offering comprehensive patient support, insurance processing, and treatment planning.

  • Enhanced educational initiatives, partnerships, and programs for prescribers, institutions, and patients.

  • Hosted Avicanna Symposium with 400+ medical professionals, reinforcing leadership in cannabinoid research.

  • Developed Morpheus patient intelligence platform for real-world data and treatment optimization.

  • Advanced clinical studies: national real-world evidence study (450+ patients) and phase II RCT for osteoarthritic pain.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Avicanna earnings date

Logotype for Avicanna Inc
Q4 202531 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Avicanna earnings date

Logotype for Avicanna Inc
Q4 202531 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Avicanna Inc. is a Canadian international commercial-stage biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products. The company operates in the global medical and pharmaceutical market segments, leveraging its established scientific platform, including research and development (R&D) and clinical development. This platform has enabled Avicanna to launch over thirty proprietary products, along with a robust pharmaceutical pipeline aimed at addressing a range of medical conditions. Avicanna's business strategy encompasses active and commercial business pillars that include medical cannabis and wellness products, as well as a medical cannabis care portal. The company is headquartered in Toronto, Canada, and its shares are listed on the Toronto Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage